Related references
Note: Only part of the references are listed.Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) - A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease)
AT Hirsch et al.
CIRCULATION (2006)
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
DL Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events
PA Ringleb et al.
STROKE (2004)
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
DL Bhatt et al.
AMERICAN HEART JOURNAL (2004)
Comparative benefits of clopidogrel and aspirin in high-risk patient populations
J Hirsh et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)